Greg Tucker-Kellogg

Specialties: Computational biology, R&D technology and strategy, genomics and genomic technology, pharmacogenomics, biomarker discovery, bioinformatics, target identification, personalized medicine, cancer

Companies

• Director, Computational Biology Programme National University of Singapore (2014)
• Professor in Practice National University of Singapore (2012)
• Visiting Professor National University of Singapore (2011 — 2012)
• Chief Technology Officer, and Senior Director Systems Biology Lilly Singapore Centre for Drug Discovery (Eli Lilly) (2007 — 2011)
• Adjunct Associate Professor, Department of Biological Sciences National University of Singapore (2005 — 2011)
• Chief Scientific Officer, Lilly Systems Biology Eli Lilly (2004 — 2007)
• Associate Director Millennium Pharmaceuticals (2000 — 2004)
• Scientific Advisory Board AnVil (2000 — 2003)
• Principal Scientist and Lab Head Genetics Institute (later Wyeth Research) (1997 — 1999)

Education

• INSEAD (2010 — 2010)
• Postdoctoral fellowship Harvard Medical School (1993.09 — 1997.06)
• Ph.D. Yale University (1986 — 1993)
• B.S Carnegie Mellon University (1982.09 — 1986.05)